University of Galway develops revolutionary approach to cancer vaccine design

Researchers at the University of Galway have developed a revolutionary approach to the design of cancer vaccines.

The study is a collaboration between labs in Germany, Sweden, the Netherlands, Spain and the US. 

Their approach to a prototype incorporates glycocluster, which has led to a much-improved immune response to the vaccine

Professor of Chemistry Paul Murphy explains how the research can be expanded to other areas of healthcare: